|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
By Industry | By Industry Segment | By Services and Suppliers
| By Location
| By Hotbed |
Profile Search
|
Otsuka America Pharmaceutical, Inc.
2440 Research Boulevard
Rockville
Maryland
20850
U.S.A.
Phone:
301-990-0030
Fax:
301-212-8620
|
Otsuka is a successful, global group of affiliated companies that discovers, develops and markets innovative products. In the U.S., Otsuka is hard at work investigating potential new treatments, with numerous compounds in various stages of development to treat disorders of the cardiovascular, gastrointestinal, respiratory, renal and central nervous systems, and to treat cancer and ophthalmic disorders. Our pharmaceutical products include ABILIFY® (aripiprazole) Tablets and intramuscular injection, IV BUSULFEX® (busulfan) Injection and PLETAL® (cilostazol) Tablets, although we no longer actively market PLETAL. We also have the BreathTek™ Urea Breath Test for H. pylori. We have numerous additional products in our pipeline that are currently under development. We are highly diversified, with pharmaceutical as well as consumer products such as Crystal Geyser Water, NatureMade® Vitamins, Ridge Wines, and diagnostic equipment.
Please visit our website at www.otsuka-us.com for more information.
Email:
Ownership:
Subsidiary
Web Site:
Otsuka America Pharmaceutical, Inc.
Employees:
Symbol:
|
|
|
Company News |
FDA Warns of Liver Injury Risk With Otsuka America Pharmaceutical, Inc.'s Tolvaptan
1/25/2013 8:40:49 AM
More...
|
Otsuka America Pharmaceutical, Inc. Opens First Office in Canada
10/4/2010 12:31:57 PM
More...
|
UK's National Institute for Clinical Excellence (NICE) Wants More Data on Bristol-Myers Squibb Company (BMY) And Otsuka America Pharmaceutical, Inc. Schizophrenia Drug Abilify
9/10/2010 8:00:19 AM
More...
|
Bristol-Myers Squibb Company (BMY) Announces Extension of U.S. Agreement for ABILIFY(R) and Establishment of an Oncology Collaboration with Otsuka America Pharmaceutical, Inc.
4/6/2009 9:53:35 AM
More...
|
Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring
2/25/2009 7:26:41 AM
More...
|
Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
2/12/2009 6:52:03 AM
More...
|
Otsuka America Pharmaceutical, Inc. Release: American Psychiatric Association Announces Recipients of 2008 Awards for Advancing Minority Mental Health; Awards Honoring Mental Health Programs Supported by a Grant from Otsuka America Pharmaceutical, Inc.
5/23/2008 2:58:16 PM
More...
|
Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
10/2/2007 8:59:22 AM
More...
|
EVEREST Data Use of Otsuka America Pharmaceutical, Inc.'s Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACC's Late Breaking Clinical Trials
3/26/2007 11:00:52 AM
More...
|
Bristol-Myers Squibb Company (BMY) Release: ABILIFY(R) (Aripiprazole) Injection For Intramuscular Use For Adults With Agitation Associated With Schizophrenia Or Bipolar Mania Now Available
12/12/2006 12:46:50 PM
More...
|
|
|
|
 |
|
|
|
|
|
|
|
|
|